CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −7,800 | $2.92 | $23K | 162,153 |
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −4,700 | $2.92 | $14K | 909,567 |
| 2023-07-25 | ORBIMED ADVISORS LLC 10% owner | Sale | −26,700 | $2.92 | $78K | 2,258,987 |
| 2023-07-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −9,800 | $2.40 | $24K | 169,953 |
| 2023-07-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −52,800 | $2.40 | $127K | 914,267 |
| 2023-07-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −132,100 | $2.40 | $317K | 2,285,687 |
| 2023-06-17 | Dallas Jayson Donald Alexander Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2023-06-14 | Shapiro David Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2023-06-14 | Prener Anne Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2023-06-14 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2023-06-14 | GOLDFISCHER CARL Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2023-06-14 | Khuong Chau Quang Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2023-04-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −660 | $1.97 | $1K | 179,753 |
| 2023-04-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −3,551 | $1.97 | $7K | 967,067 |
| 2023-04-17 | ORBIMED ADVISORS LLC 10% owner | Sale | −8,878 | $1.97 | $17K | 2,417,787 |
| 2023-04-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −2,091 | $1.86 | $4K | 180,413 |
| 2023-04-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −11,245 | $1.86 | $21K | 970,618 |
| 2023-04-14 | ORBIMED ADVISORS LLC 10% owner | Sale | −28,110 | $1.86 | $52K | 2,426,665 |
| 2023-04-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −703 | $1.82 | $1K | 182,504 |
| 2023-04-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −3,784 | $1.82 | $7K | 981,863 |
Page 5 of 12 · 227 trades